Literature DB >> 4009539

Coronary risk profile of young soldiers with coronary heart disease.

P Lynch.   

Abstract

In a retrospective study of coronary risk factors in young soldiers with coronary heart disease (CHD), designed to explain why junior ranks in the British Army have a higher mortality rate from CHD than comparable British civilians, high prevalence of heavy cigarette smoking was found to be the major discriminant. In general, young men with CHD have higher prevalence of cigarette smoking, and a higher per capita consumption than older men with CHD. They also have higher cholesterol levels, perhaps resulting from more symptomatic cases of familial hypercholesterolaemia in the younger age group. Young affected soldiers are more obese than young affected civilians and smoke more cigarettes (24% smoke 40 or more per day). This may be related to the reduced cost of cigarettes to soldiers in some parts of the world. In the British Army, the expected protective effect of physical fitness is overwhelmed by the deleterious effect of high cigarette consumption.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009539     DOI: 10.1136/jramc-131-01-09

Source DB:  PubMed          Journal:  J R Army Med Corps        ISSN: 0035-8665            Impact factor:   1.285


  3 in total

1.  Smoking rates in the staff of a military field hospital before and after wartime deployment.

Authors:  C J Boos; A M Croft
Journal:  J R Soc Med       Date:  2004-01       Impact factor: 18.000

2.  Smoking-related cancer in military veterans: retrospective cohort study of 57,000 veterans and 173,000 matched non-veterans.

Authors:  Beverly P Bergman; Daniel F Mackay; David Morrison; Jill P Pell
Journal:  BMC Cancer       Date:  2016-05-14       Impact factor: 4.638

3.  Hospital admissions for non-communicable disease in the UK military and associations with alcohol use and mental health: a data linkage study.

Authors:  L Goodwin; D Leightley; Z E Chui; S Landau; P McCrone; R D Hayes; M Jones; S Wessely; N T Fear
Journal:  BMC Public Health       Date:  2020-09-10       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.